| 2498 |
1847: SARS-CoV-2 production |
1939: Viral infection, proliferated |
Oct 24, 2021 |
Jun 29, 2024 |
1 AOP
|
| 2545 |
1847: SARS-CoV-2 production |
1870: Sustentacular cells, decrease |
Jan 5, 2022 |
Jan 5, 2022 |
1 AOP
|
| 2546 |
1847: SARS-CoV-2 production |
1931: Disruption of the intestinal barrier |
Jan 5, 2022 |
Jun 14, 2022 |
1 AOP
|
| 2329 |
1855: Increased Sodium-sensitive hypertension |
1603: Chronic kidney disease |
Apr 10, 2021 |
Apr 10, 2021 |
1 AOP
|
| 2698 |
2033: Increased S1-P |
1502: Histone deacetylase inhibition |
Jul 19, 2022 |
Jul 19, 2022 |
1 AOP
|
| 1592 |
1441: Systemic cholesterol increased |
1442: Foam cell formation |
Jun 29, 2017 |
Jun 29, 2017 |
None
|
| 3418 |
2285: the delayed and early afterdepolarizations |
1106: Occurrence, cardiac arrhythmia |
Nov 21, 2024 |
Nov 21, 2024 |
1 AOP
|
| 3412 |
2283: Early premature depolarizations |
1929: Increased incidence of cardiovascular morbidity and mortality |
Nov 21, 2024 |
Nov 21, 2024 |
1 AOP
|
| 3421 |
2283: Early premature depolarizations |
1535: Heart failure |
Nov 21, 2024 |
Nov 21, 2024 |
1 AOP
|
| 3409 |
2281: uncoordinated cardiac contraction |
1929: Increased incidence of cardiovascular morbidity and mortality |
Nov 20, 2024 |
Nov 20, 2024 |
None
|
| 3447 |
2281: uncoordinated cardiac contraction |
1535: Heart failure |
Nov 27, 2024 |
Nov 27, 2024 |
1 AOP
|
| 2315 |
1858: Increased viral transcription and replication |
1496: Increased proinflammatory mediators |
Apr 9, 2021 |
Apr 9, 2021 |
None
|
| 2316 |
1858: Increased viral transcription and replication |
1848: TLR Activation/Dysregulation |
Apr 9, 2021 |
Apr 9, 2021 |
None
|
| 1445 |
1326: Increased, 5-HT3 |
1344: Increased, seizure |
Apr 14, 2017 |
Apr 14, 2017 |
1 AOP
|
| 707 |
708: Increased, Accumulation of alpha2u microglobulin (proximal tubular epithelium) |
709: Increase, Cytotoxicity (renal tubular cell) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1706 |
1499: Activation of Th2 cells |
1500: Increased cellular proliferation and differentiation |
Jan 5, 2018 |
May 18, 2023 |
1 AOP
|
| 1073 |
1029: Increased, adipogenesis |
1032: Increased, secretion of local growth factors |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 568 |
574: Increased, Appetite and hunger |
560: Abnormal, Foraging activity and behavior |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 607 |
602: Increased, Ataxia, paralysis, or hyperactivity |
351: Increased Mortality |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3673 |
602: Increased, Ataxia, paralysis, or hyperactivity |
1005: Reduced, Swimming performance |
Oct 20, 2025 |
Oct 20, 2025 |
1 AOP
|
| 432 |
444: Increased, Atrioventricular block and bradycardia |
351: Increased Mortality |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 591 |
444: Increased, Atrioventricular block and bradycardia |
445: Respiratory distress/arrest |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2871 |
2124: increased, Bax |
55: Cell injury/death |
Apr 4, 2023 |
Apr 4, 2023 |
1 AOP
|
| 2874 |
2124: increased, Bax |
1825: Increase, Cell death |
Apr 4, 2023 |
Apr 4, 2023 |
None
|
| 3467 |
2124: increased, Bax |
1262: Apoptosis |
Jan 4, 2025 |
May 29, 2025 |
1 AOP
|